Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients

Daniel M. F. Claassens, Marieke E. Gimbel, Thomas O. Bergmeijer, Gerrit J. A. Vos, Renicus S. Hermanides, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M. Tjon Joe Gin, Evelyn A. de Vrey, Ton A. C. M. Heestermans, J. Wouter Jukema, Clemens von Birgelen, Reinier A. Waalewijn, Sjoerd H. Hofma, Frank R. den Hartog, Michiel Voskuil, Arnoud W. J. Van't Hof, Folkert W. Asselbergs, A. MosterdJean-Paul R. Herrman, Willem Dewilde, Bakhtawar K. Mahmoodi, Vera H. M. Deneer, Jurrien M. ten Berg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)10-17
Number of pages8
JournalInternational Journal of Cardiology
Volume334
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • Pharmacogenetics
  • Older
  • Genotyping
  • Myocardial infarction
  • DUAL ANTIPLATELET THERAPY
  • PRASUGREL
  • OUTCOMES
  • ABCB1

Cite this